106 related articles for article (PubMed ID: 2596736)
1. Increase of walking capacity after acute aminophylline administration in intermittent claudication.
Picano E; Testa R; Pogliani M; Lattanzi F; Gaudio V; L'Abbate A
Angiology; 1989 Dec; 40(12):1035-9. PubMed ID: 2596736
[TBL] [Abstract][Full Text] [Related]
2. [Increase in tolerance to physical effort in patients with X syndrome after acute administration of aminophylline].
Emdin M; Lattanzi F; Picano E
Medicina (Firenze); 1989; 9(2):173-5. PubMed ID: 2682120
[TBL] [Abstract][Full Text] [Related]
3. Exercise capacity after acute aminophylline administration in angina pectoris.
Picano E; Pogliani M; Lattanzi F; Distante A; L'Abbate A
Am J Cardiol; 1989 Jan; 63(1):14-6. PubMed ID: 2909150
[TBL] [Abstract][Full Text] [Related]
4. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
[TBL] [Abstract][Full Text] [Related]
5. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
Arosio E; De Marchi S; Zannoni M; Prior M; Lechi A
Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710
[TBL] [Abstract][Full Text] [Related]
6. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
Ahimastos AA; Walker PJ; Askew C; Leicht A; Pappas E; Blombery P; Reid CM; Golledge J; Kingwell BA
JAMA; 2013 Feb; 309(5):453-60. PubMed ID: 23385271
[TBL] [Abstract][Full Text] [Related]
7. Improved exercise capacity with acute aminophylline administration in patients with syndrome X.
Emdin M; Picano E; Lattanzi F; L'Abbate A
J Am Coll Cardiol; 1989 Nov; 14(6):1450-3. PubMed ID: 2809002
[TBL] [Abstract][Full Text] [Related]
8. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
9. Effect of L-carnitine on the reactive hyperemia in patients affected by peripheral vascular disease: a double-blind, crossover study.
Brevetti G; Attisano T; Perna S; Rossini A; Policicchio A; Corsi M
Angiology; 1989 Oct; 40(10):857-62. PubMed ID: 2679240
[TBL] [Abstract][Full Text] [Related]
10. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of suloctidil in intermittent claudication.
Verhaeghe R; Van Hoof A; Beyens G
J Cardiovasc Pharmacol; 1981; 3(2):279-86. PubMed ID: 6166799
[TBL] [Abstract][Full Text] [Related]
12. Placebo-controlled trial of ketanserin in the treatment of intermittent claudication.
Cameron HA; Waller PC; Ramsay LE
Angiology; 1987 Jul; 38(7):549-55. PubMed ID: 3304029
[TBL] [Abstract][Full Text] [Related]
13. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
Clement DL; Duprez D; Van Wassenhove A; Brusselmans F
Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
[TBL] [Abstract][Full Text] [Related]
14. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
Rudofsky G
Wien Klin Wochenschr; 1988 Jul; 100(14):484-8. PubMed ID: 3062906
[TBL] [Abstract][Full Text] [Related]
15. Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication.
Creager MA; Olin JW; Belch JJ; Moneta GL; Henry TD; Rajagopalan S; Annex BH; Hiatt WR
Circulation; 2011 Oct; 124(16):1765-73. PubMed ID: 21947297
[TBL] [Abstract][Full Text] [Related]
16. The effect of aminophylline infusion on the exercise capacity in patients with syndrome X.
Yeşildağ O; Yazici M; Yilmaz O; Uçar R; Sağkan O
Acta Cardiol; 1999 Dec; 54(6):335-7. PubMed ID: 10672289
[TBL] [Abstract][Full Text] [Related]
17. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
Blume J; Kieser M; Hölscher U
Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
[TBL] [Abstract][Full Text] [Related]
18. [Double-blind study of the effect of dipyridamole in patients with intermittent claudication].
Baumgartner I; Schalch I; Bollinger A
Vasa; 1992; 21(4):387-91. PubMed ID: 1485474
[TBL] [Abstract][Full Text] [Related]
19. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
[TBL] [Abstract][Full Text] [Related]
20. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
Messa GL; Gelso E
Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
